171. The debate continues: does ''undetectable'' mean ''uninfectious''?. Issue 2 (March 2009) Authors: Vernazza, Pietro L Journal: HIV therapy Issue: Volume 3:Issue 2(2009) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
172. The impact of baseline characteristics on virologic response to etravirine: 48-week pooled analysis of DUET-1 and DUET-2. Issue 5 (September 2010) Authors: Cahn, Pedro; Haubrich, Richard; Katlama, Christine; Goebel, Frank; Suter, Fredy; Peeters, Monika; Vingerhoets, Johan; Sinha, Rekha; Witek, James Journal: HIV therapy Issue: Volume 4:Issue 5(2010) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
173. The intersection between HIV and syphilis in men who have sex with men: some fresh perspectives. Issue 6 (December 2010) Authors: Drummond, Fraser; Guy, Rebecca; Kaldor, John M; Donovan, Basil Journal: HIV therapy Issue: Volume 4:Issue 6(2010) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
174. The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications. Issue 6 (November 2009) Authors: Brenner, Bluma G; Coutsinos, Dimitrios Journal: HIV therapy Issue: Volume 3:Issue 6(2009) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
175. The number of HIV-infected individuals decreases by half in India: impact on the global epidemiology of HIV/AIDS. (September 2008) Authors: Venkatesh, Kartik K; Kumarasamy, Nagalingeswaran Journal: Future HIV therapy Issue: Volume 2:Number 5(2008) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
176. The POWER and TITAN trials: darunavir/ritonavir in the management of HIV-infected patients. (May 2008) Authors: Katlama, Christine Journal: Future HIV therapy Issue: Volume 2:Number 3(2008) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
177. The prospect of APOBEC3G for the future of HIV therapy. Issue 1 (January 2009) Authors: Prochnow, Courtney; Bransteitter, Ronda; Goodman, Myron F; Chen, Xiaojiang S Journal: HIV therapy Issue: Volume 3:Issue 1(2009) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
178. The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa. (September 2008) Authors: Wallrauch, Claudia; Bäärnighausen, Till; Heller, Tom; Houlihan, Catherine; Newell, Marie-Louise Journal: Future HIV therapy Issue: Volume 2:Number 5(2008) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
179. Transcriptional gene silencing as a genetic therapy for HIV-1. (July 2008) Authors: Turner, Anne-Marie W; Morris, Kevin V Journal: Future HIV therapy Issue: Volume 2:Number 4(2008) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
180. Transmitted drug resistance in nonsubtype B HIV-1 infection. Issue 5 (September 2009) Authors: Chan, Philip A; Kantor, Rami Journal: HIV therapy Issue: Volume 3:Issue 5(2009) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗